Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v5-FR | Version v5-FR | |
---|---|---|
Language | French | French |
Date Updated | 2019-02-18 | 2019-02-18 |
Drug Identification Number | 00131237 | 00131237 |
Brand name | CONRAY 60 | CONRAY 60 |
Common or Proper name | Iothalamate Meglumine Injection 60 % | Iothalamate Meglumine Injection 60 % |
Company Name | LIEBEL-FLARSHEIM COMPANY LLC | LIEBEL-FLARSHEIM COMPANY LLC |
Ingredients | IOTHALAMATE MEGLUMINE | IOTHALAMATE MEGLUMINE |
Strength(s) | 600MG | 600MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVASCULAR | INTRAVASCULAR |
Packaging size | 20, 30 and 200 mL Bottle | 20, 30 and 200 mL Bottle |
ATC code | V08AA | V08AA |
ATC description | X-RAY CONTRAST MEDIA, IODINATED | X-RAY CONTRAST MEDIA, IODINATED |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | ||
Actual discontinuation date | 2019-02-15 | 2019-02-15 |
Remaining supply date | 2017-01-31 | 2017-01-31 |
Discontinuation status | Discontinued | Discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | ||
Health Canada comments |